Results 11 to 20 of about 8,269,032 (242)

Biophysics-based protein language models for protein engineering [PDF]

open access: yesNat Methods
Protein language models trained on evolutionary data have emerged as powerful tools for predictive problems involving protein sequence, structure, and function. However, these models overlook decades of research into biophysical factors governing protein
Sam Gelman   +7 more
semanticscholar   +2 more sources

A Bivalent COVID-19 Vaccine Based on Alpha and Beta Variants Elicits Potent and Broad Immune Responses in Mice against SARS-CoV-2 Variants

open access: yesVaccines, 2022
With the emergence and rapid spread of new pandemic variants, especially variants of concern (VOCs), the development of next-generation vaccines with broad-spectrum neutralizing activities is of great importance.
Rui Wang   +19 more
doaj   +1 more source

In vivo pharmacokinetic enhancement of monomeric Fc and monovalent bispecific designs through structural guidance

open access: yesCommunications Biology, 2021
Lu Shan et al. present a structure-guided approach to engineer a monovalent form of the fragment crystallizable (Fc) region of an IgG4 antibody to adapt multiple versions of half-life extension modifications and bispecific targeting.
Lu Shan   +12 more
doaj   +1 more source

FHF1 is a bona fide fibroblast growth factor that activates cellular signaling in FGFR-dependent manner

open access: yesCell Communication and Signaling, 2020
Fibroblast growth factors (FGFs) via their receptors (FGFRs) transduce signals from the extracellular space to the cell interior, modulating pivotal cellular processes such as cell proliferation, motility, metabolism and death. FGF superfamily includes a
Martyna Sochacka   +7 more
doaj   +1 more source

N-glycosylation acts as a switch for FGFR1 trafficking between the plasma membrane and nuclear envelope

open access: yesCell Communication and Signaling, 2023
Fibroblast growth factor receptor 1 (FGFR1) is a heavily N-glycosylated cell surface receptor tyrosine kinase that transmits signals across the plasma membrane, in response to fibroblast growth factors (FGFs).
Paulina Gregorczyk   +8 more
doaj   +1 more source

Low-N protein engineering with data-efficient deep learning

open access: yesNature Methods, 2020
Protein engineering has enormous academic and industrial potential. However, it is limited by the lack of experimental assays that are consistent with the design goal and sufficiently high throughput to find rare, enhanced variants.
Surojit Biswas   +4 more
semanticscholar   +1 more source

Polymerase-guided base editing enables in vivo mutagenesis and rapid protein engineering

open access: yesNature Communications, 2021
Random mutagenesis is a technique used to generate diversity and engineer biological systems. In vivo random mutagenesis generates diversity directly in a host organism, enabling applications such as lineage tracing, continuous evolution, and protein ...
Aaron Cravens   +4 more
semanticscholar   +1 more source

Protein Engineering Strategies for Improved Pharmacokinetics

open access: yesAdvanced Functional Materials, 2021
Protein therapeutics have gained momentum in recent years and become a pillar in treating many diseases and the only choice in several ailments. Protein therapeutics are highly specific, tunable, and less toxic than conventional small drug molecules ...
Aurélie Rondon   +4 more
semanticscholar   +1 more source

Identification of a novel peptide ligand for the cancer-specific receptor mutation EGFRvIII using high-throughput sequencing of phage-selected peptides

open access: yesScientific Reports, 2022
We report here the selection and characterization of a novel peptide ligand using phage display targeted against the cancer-specific epidermal growth factor tyrosine kinase receptor mutation variant III (EGFRvIII).
Sourour Mansour   +9 more
doaj   +1 more source

A Polysaccharide-RBD-Fc-Conjugated COVID-19 Vaccine, SCTV01A, Showed High Immunogenicity and Low Toxicity in Animal Models

open access: yesVaccines, 2023
We previously developed a polysaccharide-–RBD-conjugated nanoparticle vaccine which induced protective efficacy against SARS-CoV-2 in a mouse model. Here, we newly developed a vaccine, SCTV01A, by chemically conjugating recombinant SARS-CoV-2 RBD-Fc and ...
Chunyun Sun   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy